An LC–MS/MS method for quantification of HR011303, a novel highly selective urate transporter 1 inhibitor in beagle dogs and the application to a pharmacokinetic study

HR011303 is a novel and highly selective urate transporter 1 (URAT1) inhibitor. In this study, a sensitive liquid chromatography–tandem mass spectrometry (LC–MS/MS) method was developed and validated for quantification of HR011303 in beagle dog plasma. Plasma samples were pretreated with protein‐precipitation extraction by acetonitrile and added with a trifluoromethyl substituted analog of HR011303 as internal standard. The chromatographic separation was performed on a Shiseido C₁₈ column (100 × 4.6 mm, i.d., 5 μm) by mobile phases consisting of 5 mm ammonium–formic acid (100:0.1) and acetonitrile–formic acid (100:0.1) solutions in gradient elution. The MS detection was conducted in electrospray positive ionization with multiple reactions monitoring at m/z 338 → 240 for HR011303 and m/z 328 → 230 for the internal standard using 25 eV argon gas collision induced dissociation. The established LC–MS/MS method showed good selectivity, sensitivity, precision and accuracy. The plasma pharmacokinetics of HR011303 in beagle dogs following both oral and intravenous administration were then successfully evaluated using this LC–MS/MS method.     

Uric acid quantification in fingernail of gout patients and healthy volunteers using HPLC‐UV

The presence of elevated uric acid (UA) levels is a sign of gout, that is, hyperuricemia. In this study the monitoring of the UA levels in less‐invasive biological samples, such as the human fingernail, is suggested for the diagnosis and therapy of gout. Twenty‐six healthy volunteers (HV) and 22 gout patients (GP) were studied. The UA was extracted from human fingernail samples, then separated on an Inertsil ODS‐3 column (250 × 4.6 mm i.d., 4.0 μm, GL Sciences) by isocratic elution using methanol–74 mm phosphate buffer (pH 2.2) 2:98 (v/v). A UV detector was used to monitor the samples at 284 nm. Using the developed method, different UA concentrations were found in the GP and HV. When comparing the concentrations from GP with those from HV, a statistically significant correlation was observed between the UA (p < 0.01). In this study, the UA was confirmed as a potential biomarker for the diagnosis and therapy of gout. We have developed a novel sensitive, and simple method for the determination of UA in the fingernails of GP and HV. The human fingernail may serve as a noninvasive biosample for the diagnosis of gout. Copyright © 2016 John Wiley & Sons, Ltd.     

Simultaneous quantification of urinary purines and creatinine by ultra high performance liquid chromatography with ultraviolet spectroscopy and quadrupole time‐of‐flight mass spectrometry: Method development,validation, and application to gout study

We present an ultra high performance liquid chromatography with ultraviolet spectroscopy and quadrupole time‐of‐flight mass spectrometry method for the simultaneous quantification of ten purines (adenine, hypoxanthine, guanine, xanthine, deoxyadenosine, adenosine, inosine, guanosine, xanthosine, and uric acid) and creatinine in human urine. After chromatographic separation on an ACE Excel 2 AQ column, high abundant creatinine and uric acid and the other low abundant purines were sequentially detected by ultraviolet and quadrupole time‐of‐flight mass spectrometry within a single run. Method validations including specificity (improved by accurate mass measurement), linearity (correlation coefficients ≥0.9944), limit of quantification (0.002–9.756 µg/mL), intra‐ and interday precision (relative standard deviations ≤9.1 and 14.0%, respectively), accuracy (relative errors ≤13.1%), extraction recovery (between 90.3 and 109.6%), matrix effect (between 85.3 and 110.5%), and stability (relative errors ≤14.3%) were fully evaluated. This approach was applied to characterize the disordered purine metabolism in acute and chronic gout as an example. Quantitative results (normalized by creatinine) showed that an overproduction of urinary purine precursors might be involved in the gout process. The developed method represents a useful tool to investigate the purine disturbances in gout and other relevant diseases.     

模块式护理计划对痛风患者疼痛及生活质量的影响分析

目的研究分析痛风患者采取模块式护理计划后对其生活质量、疼痛的影响。方法将佛山市第一人民医院风湿免疫内科2015年12月至2016年11月经临床诊断为痛风的住院患者156例随机分为常规组和实验组各78例,常规组采取常规护理措施,实验组采取模块式护理计划,比较两组患者的疼痛评分、疼痛缓解时间、生活质量评分。结果实验组、常规组疼痛缓解时间分别为(4.6±1.8)d、(7.3±2.7)d,(P0.05),护理2周后疼痛评分分别为(1.9±1.1)分、(4.1±2.5)分,(P0.05),生活质量评分分别为(8.2±2.6)分、(4.9±1.5)分,(P0.05)。结论模块式护理计划应用于痛风患者的护理中,能够显著降低患者的疼痛程度,提升其生活质量,缩短疼痛缓解时间,提高护理质量及效率,建议推广使用。     

Growth and characterization of gel grown calcium pyrophosphate tetrahydrate crystals

Formation of calcium pyrophosphate dihydrate (CPPD) crystals in soft tissues such as cartilage, meniscus and synovial tissues lead afflictions. The appearance of these crystals in the synovial fluid give rise to acute arthritis attack, which is known as pseudo‐gout. The growth of calcium pyrophosphate crystals in gel medium can mimic the growth in a body. In the present study, calcium pyrophosphate tetrahydrate (CPPT) crystals are grown by a single diffusion gel growth technique and characterized by powder XRD, FT‐IR spectroscopy, TGA, kinetic and thermodynamic studies of dehydration and dielectric studies. Monoclinic crystals structure, presence of P‐O bonds and four water molecules are confirmed from powder XRD, FT‐IR and TGA studies, respectively. The dielectric investigation suggests the reduction in dielectric constant with increase in frequency. (© 2007 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim)     

Phloroglucinol Derivatives from Dryopteris crassirhizoma as Potent Xanthine Oxidase Inhibitors

Dryopteris crassirhizoma rhizomes are used as a traditional medicine in Asia. The EtOAc extract of these roots has shown potent xanthine oxidase (XO) inhibitory activity. However, the main phloroglucinols in D. crassirhizoma rhizomes have not been analyzed. Thus, we investigated the major constituents responsible for this effect. Bioassay-guided purification isolated four compounds: flavaspidic acid AP (1), flavaspidic acid AB (2), flavaspidic acid PB (3), and flavaspidic acid BB (4). Among these, 1 showed the most potent inhibitory activity with a half-maximal inhibitory concentration (IC₅₀) value of 6.3 µM, similar to that of allopurinol (IC₅₀ = 5.7 µM) and better than that of oxypurinol (IC₅₀ = 43.1 µM), which are XO inhibitors. A comparative activity screen indicated that the acetyl group at C3 and C3′ is crucial for XO inhibition. For example, 1 showed nearly 4-fold higher efficacy than 4 (IC₅₀ = 20.9 µM). Representative inhibitors (1–4) in the rhizomes of D. crassirhizoma showed reversible and noncompetitive inhibition toward XO. Furthermore, the potent inhibitors were shown to be present in high quantities in the rhizomes by a UPLC-QTOF-MS analysis. Therefore, the rhizomes of D. crassirhizoma could be used to develop nutraceuticals and medicines for the treatment of gout.     

含萘三氮唑甲烷骨架的硫代乙酸类尿酸转运体1(URAT1)抑制剂的合成及其构效关系

分别以1-溴萘和酮或1-萘甲醛及有机金属试剂为原料,经12步反应合成了8个含萘三氮唑甲烷骨架的硫代乙酸类尿酸转运体1(URAT1)抑制剂(1h~1o),其结构经¹H NMR, ¹³C NMR和MS（ESI）表征。体外活性测试结果显示：对URAT1的抑制活性最强的是1k,是阳性对照药lesinurad的133倍［IC₅₀=0.054 μmol·L^-1(1k), 7.18 μmol·L^-1(lesinurad)］。     

壳聚糖/氮掺杂还原氧化石墨烯修饰电极对黄嘌呤的检测及尿酸抑制的研究

用碳热还原法制备氮掺杂还原氧化石墨烯（N-RGO）,用壳聚糖（CS）的乙酸溶液作为氮掺杂还原氧化石墨烯（N-RGO）的分散剂,将其修饰在玻碳电极表面,用于检测黄嘌呤（xanthine）.该传感器对黄嘌呤展现出优异的电化学响应,线性范围为2.99×10^-8~1.07×10^-4 mol/L,检测限为9.96×10^-9 mol/L（S/N=3）.此外,利用循环伏安法（CV）对黄嘌呤电化学行为进行了研究.最后,用电化学的方法研究了非布索坦（Febuxostat）和别嘌呤醇（Allopurinol）两种药物对尿酸生成的抑制.本工作为痛风的诊断和治疗提供了重要的信息.     

Determination of purine contents of alcoholic beverages using high performance liquid chromatography

The purine contents of alcoholic beverages were determined in order to utilize them in the dietary care of gout and hyperuricemia. In the management of these diseases, restriction of both alcohol and purine intake are important. The method employed in this study is a quantitative determination of purine contents by HPLC. Alcoholic beverages were hydrolyzed to corresponding purine bases, which were then separated by HPLC, and base peaks were identified using an enzymatic peak‐shift technique. This method is sufficiently accurate and reproducible to examine the purine contents of various alcoholic beverages that patients consume. Purine contents were as follows: spirits, 0.7–26.4 µmol/L; regular beer, 225.0–580.2 µmol/L; low‐malt beer, 193.4–267.9 µmol/L; low‐malt and low‐purine beer, 13.3 µmol/L; other liquors, 13.1–818.3 µmol/L. Some local and low‐alcohol beers were found to contain about 2.5 times more purines than regular beer. As some alcoholic beverages contain considerable amounts of purines, we recommend that excess consumption of these beverages be avoided. These data should be useful in the management of hyperuricemia and gout, not only for patients but also for physicians. Copyright © 2009 John Wiley & Sons, Ltd.     

A Hydrogel Sensing Pathological Urate Concentrations

Metabolite‐responsive hydrogels that detect pathological metabolite concentrations and react by releasing a therapeutic stimulus hold high promises in treating metabolic diseases. In this study, a hydrogel is described that discriminates between physiological and pathological concentrations of urate, the causative agent of gouty arthritis. The hydrogel is synthesized by coupling a dimeric variant of the Deinococcus radiodurans‐derived urate repressor HucR to linear polyacrylamide. The protein‐grafted polymer is crosslinked to form a hydrogel by a multimeric hucO DNA sequence [hucO]_n specifically binding HucR. At elevated urate concentrations, HucR dissociates from [hucO]_n thereby weakening the hydrogel structure and resulting in its dissolution.